1. Home
  2. CABO vs CSTL Comparison

CABO vs CSTL Comparison

Compare CABO & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cable One Inc.

CABO

Cable One Inc.

HOLD

Current Price

$120.50

Market Cap

603.1M

ML Signal

HOLD

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$39.11

Market Cap

661.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CABO
CSTL
Founded
1980
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Cable & Other Pay Television Services
Medical Specialities
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
603.1M
661.7M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
CABO
CSTL
Price
$120.50
$39.11
Analyst Decision
Hold
Strong Buy
Analyst Count
3
6
Target Price
$126.00
$38.67
AVG Volume (30 Days)
153.0K
531.8K
Earning Date
11-06-2025
11-03-2025
Dividend Yield
4.88%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,524,897,000.00
$343,530,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
10.15
52 Week Low
$96.67
$14.59
52 Week High
$428.14
$40.61

Technical Indicators

Market Signals
Indicator
CABO
CSTL
Relative Strength Index (RSI) 45.50 78.03
Support Level $96.67 $38.64
Resistance Level $109.85 $40.61
Average True Range (ATR) 7.24 1.45
MACD 2.82 0.11
Stochastic Oscillator 84.03 80.79

Price Performance

Historical Comparison
CABO
CSTL

About CABO Cable One Inc.

Cable One Inc. is a telecommunications company that generates revenue from providing broadband, voice, and video services to both residential and business customers. From a product standpoint, the majority of revenue comes from data and video services, which are subscription-based and billed monthly. The company also offers Sparklight TV, an Internet Protocol Television (IPTV) service that enables customers using the Sparklight TV app to stream video channels from the cloud. Additionally, the company earns advertising revenue by selling airtime on its video channels, and it provides voice services over Internet protocols. Cable One Inc. owns its telecommunications infrastructure.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

Share on Social Networks: